Mediastinal Lymphoma — Trials

Mediastinal Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

141 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 63
Recruiting: 36
Ph III recruiting: 1
Growth YoY: —
Industry share: 22%
Top sponsor: University of Washington
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01760226	Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies(DA-EPOCH-R)	completed	Early Phase 1	4	Baylor College of MedicineOTHER	1	Oct 14, 2025	clinicaltrials

Data updated 22 days agoSource updated Oct 14, 2025source: clinicaltrials